Peter Naredi

5.9k total citations
130 papers, 2.5k citations indexed

About

Peter Naredi is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Peter Naredi has authored 130 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 28 papers in Surgery and 27 papers in Immunology. Recurrent topics in Peter Naredi's work include Pancreatic and Hepatic Oncology Research (19 papers), Mast cells and histamine (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (15 papers). Peter Naredi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Mast cells and histamine (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (15 papers). Peter Naredi collaborates with scholars based in Sweden, United States and United Kingdom. Peter Naredi's co-authors include Kristoffer Hellstrand, Per Lindnér, Malin Sund, Christina Lundin, Gautam Kao, Svante Hermodsson, Mikael Öman, Dennis D. Heath, Stephen B. Howell and Peter Lundgren and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Peter Naredi

128 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Naredi Sweden 29 1.1k 610 485 274 260 130 2.5k
Yuan Li Shen China 26 805 0.7× 657 1.1× 333 0.7× 325 1.2× 162 0.6× 75 2.6k
Susan L. Kelley United States 17 888 0.8× 1.3k 2.2× 642 1.3× 281 1.0× 290 1.1× 26 3.4k
Helen H.W. Chen Taiwan 27 1.1k 1.0× 953 1.6× 324 0.7× 537 2.0× 221 0.8× 60 2.8k
Wolfgang Hilbe Austria 33 1.3k 1.2× 1.2k 2.0× 349 0.7× 794 2.9× 318 1.2× 129 3.9k
Michael B. Jameson New Zealand 25 780 0.7× 737 1.2× 344 0.7× 309 1.1× 86 0.3× 104 2.0k
Lionel D. Lewis United States 36 1.7k 1.5× 1.4k 2.4× 595 1.2× 806 2.9× 245 0.9× 167 4.2k
Ying Xiong China 29 726 0.6× 821 1.3× 396 0.8× 578 2.1× 253 1.0× 134 2.3k
Zheng Yang United States 36 845 0.8× 1.3k 2.2× 336 0.7× 197 0.7× 160 0.6× 107 3.5k
Soo Jung Park South Korea 34 868 0.8× 858 1.4× 475 1.0× 555 2.0× 1.1k 4.1× 201 3.6k
Nader Hanna United States 30 1.5k 1.3× 804 1.3× 358 0.7× 736 2.7× 836 3.2× 111 3.0k

Countries citing papers authored by Peter Naredi

Since Specialization
Citations

This map shows the geographic impact of Peter Naredi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Naredi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Naredi more than expected).

Fields of papers citing papers by Peter Naredi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Naredi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Naredi. The network helps show where Peter Naredi may publish in the future.

Co-authorship network of co-authors of Peter Naredi

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Naredi. A scholar is included among the top collaborators of Peter Naredi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Naredi. Peter Naredi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydin, Ebru, Roberta Kiffin, Johan Bourghardt Fagman, et al.. (2024). Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer. Cancer Research Communications. 4(4). 1135–1149. 2 indexed citations
2.
Holmberg, Erik, et al.. (2024). Risks and use of ERCP during the diagnostic workup in a national cohort of biliary cancer. Surgical Endoscopy. 39(2). 991–1001. 1 indexed citations
4.
Gallego, Pablo, et al.. (2022). Identification of C. elegans ASNA-1 domains and tissue requirements that differentially influence platinum sensitivity and growth control. PLoS Genetics. 18(12). e1010538–e1010538. 2 indexed citations
6.
Eilard, Malin Sternby, Mats Andersson, Peter Naredi, et al.. (2019). A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation. BMC Cancer. 19(1). 568–568. 22 indexed citations
7.
Nyström, Hanna, et al.. (2015). Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement. Tumor Biology. 36(12). 9839–9847. 20 indexed citations
8.
Lyth, Johan, Hanna Eriksson, Johan Hansson, et al.. (2014). Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. British Journal of Dermatology. 172(3). 700–706. 30 indexed citations
9.
Velde, Cornelis J.�H. van de, Petra G. Boelens, Pieter J. Tanis, et al.. (2013). Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012. European Journal of Surgical Oncology. 40(4). 454–468. 49 indexed citations
10.
Eriksson, Hanna, Johan Lyth, Eva Månsson‐Brahme, et al.. (2013). Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden. European Journal of Cancer. 49(12). 2705–2716. 58 indexed citations
11.
Nyström, Hanna, Peter Naredi, Å. Berglund, et al.. (2012). 190. Liver-metastatic potential of colorectal cancer is related to stromal composition of the tumor. European Journal of Surgical Oncology. 38(9). 795–796. 2 indexed citations
12.
Nyström, Hanna, Peter Naredi, Å. Berglund, et al.. (2012). Liver-metastatic potential of colorectal cancer is related to the stromal composition of the tumour.. PubMed. 32(12). 5183–91. 32 indexed citations
13.
Naredi, Peter, et al.. (2012). A Directed RNAi Screen Based on Larval Growth Arrest Reveals New Modifiers of C. elegans Insulin Signaling. PLoS ONE. 7(4). e34507–e34507. 10 indexed citations
14.
Hemmingsson, Oskar, et al.. (2010). ASNA-1 Activity Modulates Sensitivity to Cisplatin. Cancer Research. 70(24). 10321–10328. 21 indexed citations
15.
Mattsson, Jan, Leif Bergkvist, Avni Abdiu, et al.. (2008). Sentinel node biopsy in malignant melanoma: Swedish experiences 1997–2005. Acta Oncologica. 47(8). 1519–1525. 16 indexed citations
17.
Kao, Gautam, et al.. (2007). ASNA-1 Positively Regulates Insulin Secretion in C. elegans and Mammalian Cells. Cell. 128(3). 577–587. 98 indexed citations
18.
Hansson, Markus, Svante Hermodsson, Mats Brune, et al.. (1999). Histamine Protects T Cells and Natural Killer Cells Against Oxidative Stress. Journal of Interferon & Cytokine Research. 19(10). 1135–1144. 81 indexed citations
19.
Holmberg, Stig B., Peter Naredi, Ingvar Karlberg, et al.. (1995). Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours?an experimental study in rats. Journal of Cancer Research and Clinical Oncology. 121(8). 463–468. 3 indexed citations
20.
Hafström, Larsolof, Stig B. Holmberg, Peter Naredi, et al.. (1994). Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surgical Oncology. 3(2). 103–108. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026